Join Now

Category Archives: BioUtah News

Pfizer Completes Acquisition of Arena Pharmaceuticals

Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases

| Tagged | Leave a comment

PolarityTE Announces $5.0 Million Registered Direct Offering

PolarityTE Announces $5.0 Million Registered Direct Offering

| Tagged | Leave a comment

Senate HELP Committee Advances PREVENTS Pandemic Act

The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act.

Also posted in Policy News | | Leave a comment

Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program

Co-Diagnostics announced that its Board of Directors has authorized a share repurchase program that would allow the Company to repurchase up to $30 million of CODX common stock.

| Tagged , | Leave a comment

Tillis, Coons, Cotton, Hirono, and Scott Introduce Bipartisan Bill to Prevent the Chinese Communist Party from Stealing American Intellectual Property

Legislation would combat corrupt Chinese Courts from issuing “anti-suit injunctions” that prevent companies from challenging patent infringement from Chinese companies in American courts.

| Leave a comment

2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit is a Raging Success

The 2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit presented by BioUtah, BioHive and the PIVOT Center attracted a record setting 300+ registrants along with an impressive line-up of distinguished speakers, national and local investors and numerous Utah life sciences startups. Now in its 7th year, the Summit (our first in person since COVID-19) […]

| Leave a comment

Xenter Selects New Headquarters in Draper

Xenter has leased 30,000 square feet to accommodate explosive growth in the new Irvine Office Park in Draper, Utah.

| Tagged | Leave a comment

Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform

myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all Renalytix healthcare provider partners

| Tagged | Leave a comment

IONIQ Sciences announces IP acquisition and License buyout

IONIQ Sciences announced that it has acquired from OT Acceptance, LLC certain intellectual property formerly licensed to the Company by OT Acceptance.

| Tagged | Leave a comment

Metastatic Tumor Treatment with Novel GPX Embolic Device

Innovative Embolic Device by Fluidx Medical Used Successfully in a Variety of Complex Cancer Cases

| Tagged | Leave a comment

Known Medicine Partners with Duke University to Predict Lung Cancer Response to Drug Treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer

| Tagged | Leave a comment

Halia Therapeutics New Leadership Team

Halia Therapeutics New Leadership Team

| Tagged | Leave a comment